Mass-DAC

The Massachusetts Data Analysis Center (Mass-DAC)

was a data-coordination center active 2002 through 2017, in response to a state mandate, provides expert evaluation of cardiac surgery and angioplasty data  in the Commonwealth of Massachusetts.  Mass-DAC collected and validated patient-specific clinical data from all Massachusetts hospitals that provide cardiac surgery or percutaneous coronary interventions.  This data was used to monitor the quality of cardiac care delivered in the Commonwealth to improve the level of care provided.

In appreciation for Dr. Normand's contributions as Director of Mass-DAC, she was honoured with the Outstanding Lifetime Achievement Award by the Council on Quality of Care and Outcomes Research (QCOR) of the American Heart Association (AHA) at the QCOR Annual Meeting in April 2017. 

In 2012, Dr. Normand received the Distinguished Scientist award from the American Heart Association due to her national and international leadership in the development of innovative statistical methods for health services and outcomes research.  John Rumsfeld MD, PhD, former QCOR chair, said:

“Normand has demonstrated leadership in her field, and the impact of her work has been far-reaching. Her unique combination of high-level scholarship, creativity and remarkable interpersonal skills has led her work to change the way investigators approach their own research. Without question, she is considered one of the preeminent biostatisticians in the country and is certainly among the most influential individuals in health services and outcomes research.”

Presentations

  1. Normand S-L. Limitations of Analyses in Continuous Quality Improvement: Accuracy. American College of Cardiology Scientific Sessions. March 2005.
  2. Stevens L. Coronary Artery Bypass Grafting after Uneventful Percutaneous Coronary Intervention in the Commonwealth of Massachusetts. American Heart Association Scientific Sessions, November 2007.
  3. Shapira O. The Association of Race and of Insurance with Utilization and Outcomes after Coronary Artery Bypass Grafting Surgery in Massachusetts. American Heart Association Scientific Sessions, November 2007.
  4. Mauri L. Long-Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts. American Heart Association Scientific Sessions, November 2007.
  5. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand S-LT. Long-Term Clinical Outcomes Following Drug-Eluting and Bare-Metal Stenting for Acute Myocardial Infarction in Massachusetts. American College of Cardiology Scientific Sessions, March 2008.
  6. Garg P, Normand S-LT, Silbaugh T, Wolf R, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L.  Drug-eluting or bare metal stenting in patients with diabetes mellitus: Results from the Mass-DAC registry. American Heart Association Scientific Sessions, November 2008.
  7. Sakhuja R, Silbaugh T, Varma M, Normand S-L, Mauri L. Drug-Eluting Stent Use in Acute Myocardial Infarction: Do Data Drive Practice? American College of Cardiology Scientific Sessions. March 2009.
  8. Barringhaus KG, Zelevinsky K, Lovett A, Normand S-L, Ho KKL. Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2009.
  9. Anis A, Normand S-L, Wolf RE, Lovett A, Mauri L, Patel N, and Jacobs AK. Outcomes Following Primary Percutaneous Coronary Intervention: A Comparison between Hospitals with and without Cardiac Surgery On-Site. American Heart Association Scientific Sessions. November 2009.
  10. Charytan DM, Varma MR, Silbaugh TS, Lovett AF, Normand S-LT, Mauri L. Long term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients with Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. American Heart Association Scientific Sessions. November 2009.
  11. Khurana R. Independent US Validation of the British Columbia PCI Risk Score. American College of Cardiology Scientific Sessions. March 2010.
  12. Forman DE, Vasaiwala S, Silbaugh TS, Lovett A, Normand S-L, Mauri L. Acute and 3-year Bleeding Risks: Comparing Drug-Eluting to Bare-Metal Stents in Old and Very Old Adults in a Community Population. American Heart Association Scientific Sessions. November 2010.
  13. Yeh RW, Zelevinsky K, Normand S-LT, Sakhuja R, Lovett A, Weiner BH, Rosenfield KA. 30-Day All-Cause Readmission After Percutaneous Coronary Intervention in Massachusetts: Clinical Predictors and Hospital-Variation of a New Quality Metric. American Heart Association Scientific Sessions. November 2010.
  14. Ali MJ, Nedeljkovic ZS, Zelevinsky K, Lovett A, Normand S-LT, Jacobs AK. Mortality in STEMI Patients Undergoing Inter-Hospital Transfer for Primary PCI in Massachusetts. American Heart Association Scientific Sessions. November 2010.
  15. Albert MA, Silbaugh TS, Ayanian JZ, Lovett A, Wolf RE, Zelevinsky K, Resnic F, Normand S-LT. Impact of Massachusetts Health Care Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care. American Heart Association Scientific Sessions. November 2010.
  16. Normand S-LT, Treacy S. Silbaugh, Zelevinsky K, Wolf RE, Cioffi M, Lovett A, Resnic FS, Ho KKL. Hospital Quality Following Percutaneous Coronary Intervention: Massachusetts Experience From 2003-2007. American Heart Association Scientific Sessions. November 2010.
  17. Kato NS, Cioffi M, Normand S-LT. Implantable Cardioverter Defibrillator Usage in the Commonwealth of Massachusetts – A 10 Year Study. American Heart Association Scientific Sessions. November 2010.
  18. Kato NS, Cioffi M, Normand S-LT. Unsupported Implantable Cardioverter Defibrillator Use in the Commonwealth of Massachusetts - 1997 to 2008. American Heart Association Scientific Sessions. November 2010.
  19. Cubeddu RJ, Lago RM, Zelevinsky K, Lovett AF, Mendoza I, Crane AM, Witzke CF, Normand S-LT, Pomerantsev E, Palacios IF. No Mortality Advantage of “On” versus “Off”-hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry. American Heart Association Scientific Sessions. November 2010.
  20. Normand S-LT, Silbaugh TS, Zelevinsky K, Wolf RE, Cioffi M, Lovett A, Resnic FS, Ho KKL. Hospital-quality Following Percutaneous Coronary Intervention: Massachusetts Experience From 2003-2007. American College of Cardiology Scientific Sessions. May 2010.
  21. Anis A, Normand S-LT, Wolf RE, Lovett A, Mauri L, Patel N, and Jacobs AK. Primary Percutaneous Coronary Intervention With or Without Cardiac Surgery On-Site: Massachusetts’ Experience. American Heart Association Scientific Sessions. November 2010.
  22. Yeh RW, Jones PG, Wolf RE, Normand S-LT, Cohen DJ, Ho KKL, Cutlip DE, Kugelmass AD, Spertus JA. Predicting the Restenosis Benefit of Drug-Eluting vs. Bare Metal Stenting Prior to Angiography: A Tool for Patients and Clinicians. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2010.
  23. Kato NS, Cioffi M, Normand S-LT. Internal Cardioverter Defibrillator Utilization in the Commonwealth of Massachusetts - 1997 to 2008. American College of Cardiology Scientific Sessions. March 2011.
  24. Vasaiwala S, Normand S-LT, Silbaugh TS, Forman D, Baron S, Lovett A, Mauri L. Impact of Completeness of Revascularization on Late Mortality in an Unrestricted Patient Population Undergoing Percutaneous Coronary Intervention with Drug-Eluting or Bare-Metal Stents. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011.
  25. Forman D, Vasaiwala S, Silbaugh TS, Lovett A, Normand S-LT, Mauri L. Assessing utility of drug-eluting stents in coronary patients aged 85 years and older. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011.
  26. Yeh RW, Normand S-LT, Mauri L, Wolf RE, Cohen DJ, Ho KKL, Spertus JA. Does the Expected Reduction in Restenosis from Drug-Eluting Stents Predict Actual Use? An Assessment of Treatment-Risk Paradox Using the C-statistic. American Heart Association Quality of Care and Outcomes Research Scientific Sessions. May 2011.
  27. Vasaiwala S, Forman D, Yeh RW, Silbaugh TS, Lovett A, Normand S-LT, and Mauri L. Selective Drug-Eluting Stent Use in Elderly Patients: Impact on Percutaneous Coronary Intervention Mortality and Bleeding Risk. American College of Cardiology Scientific Sessions. March 2012.
  28. Cubeddu R, Lago R, Zelevinsky K, Lovett A, Mendoza I, Crane A, Witzke C, Normand S-L, Pomerantsez E, Palacio I. No Mortality Advantage of “On” versus “Off”-hours Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Results from the Massachusetts Data Analysis Center Registry.
  29. Sarma A, Normand S-LT, Hatfield L, Matheny M, Resnic F. The Learning Curve for Medical Devices: Experience with Vascular Closure Devices in Massachusetts. American College of Cardiology Scientific Sessions. March 2013. American Heart Association Scientific Sessions. November 2012.
  30. Yeh RW, Mauri L, Wold R, Romm I, Lovett A, Normand S-L. Steep Declines in Population Rates of Coronary Revascularization. American Heart Association Scientific Sessions. November 2013.
  31. Yeh RW, Mauri L, Wolf RE, Romm IK, Biondolillo M, Lovett A, Normand S-LT. Steep Declines in Population Rates of Coronary Revascularization. American College of Cardiology Scientific Sessions. March 2014.
  32. Adhikari S, Normand S-L T. Non-parametric Bayesian Instrumental Variable Analysis: Comparing effectiveness of radial vs femoral arteries access Percutaneous Coronary Intervention (PCI) in reducing bleeding and vascular complications. EMR-IBS and Italian Region Conference. May 2017.

Publications

2007

David Shahian, Treacy Silverstein, Ann Lovett, Robert Wolf, and Sharon-Lise Normand. 2007. “Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards”. Circulation, 115, 12, Pp. 1518-27. doi:10.1161/CIRCULATIONAHA.106.633008
David Shahian, Treacy Silverstein, Ann Lovett, Robert Wolf, and Sharon-Lise Normand. 2007. “Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards”. Circulation, 115, 12, Pp. 1518-27. doi:10.1161/CIRCULATIONAHA.106.633008
Sharon-Lise T. Normand and David M. Shahian. 2007. “Statistical and Clinical Aspects of Hospital Outcomes Profiling”. Statistical Science, 22, Pp. 206–226
Sharon-Lise T. Normand and David M. Shahian. 2007. “Statistical and Clinical Aspects of Hospital Outcomes Profiling”. Statistical Science, 22, Pp. 206–226

2005

David Shahian, David Torchiana, Richard Shemin, James Rawn, and Sharon-Lise Normand. 2005. “Massachusetts Cardiac Surgery Report Card: Implications of Statistical Methodology”. Ann Thorac Surg, 80, 6, Pp. 2106-13. doi:10.1016/j.athoracsur.2005.06.078
David Shahian, David Torchiana, Richard Shemin, James Rawn, and Sharon-Lise Normand. 2005. “Massachusetts Cardiac Surgery Report Card: Implications of Statistical Methodology”. Ann Thorac Surg, 80, 6, Pp. 2106-13. doi:10.1016/j.athoracsur.2005.06.078
David M Shahian, David F Torchiana, and Sharon-Lise T Normand. 2005. “Implementation of a Cardiac Surgery Report Card: Lessons from the Massachusetts Experience.”. The Annals of Thoracic Surgery, 80, 3, Pp. 1146-50
David M Shahian, David F Torchiana, and Sharon-Lise T Normand. 2005. “Implementation of a Cardiac Surgery Report Card: Lessons from the Massachusetts Experience.”. The Annals of Thoracic Surgery, 80, 3, Pp. 1146-50

2008

Justin Timbie, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2008. “A Cost-Effectiveness Framework for Profiling the Value of Hospital Care”. Med Decis Making, 28, 3, Pp. 419-34. doi:10.1177/0272989X07312476
Justin Timbie, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2008. “A Cost-Effectiveness Framework for Profiling the Value of Hospital Care”. Med Decis Making, 28, 3, Pp. 419-34. doi:10.1177/0272989X07312476
David Shahian and Sharon-Lise Normand. 2008. “Comparison of ‘risk-Adjusted’ Hospital Outcomes”. Circulation, 117, 15, Pp. 1955-63. doi:10.1161/CIRCULATIONAHA.107.747873
David Shahian and Sharon-Lise Normand. 2008. “Comparison of ‘risk-Adjusted’ Hospital Outcomes”. Circulation, 117, 15, Pp. 1955-63. doi:10.1161/CIRCULATIONAHA.107.747873
Sharon-Lise Normand. 2008. “Some Old and Some New Statistical Tools for Outcomes Research”. Circulation, 118, 8, Pp. 872-84. doi:10.1161/CIRCULATIONAHA.108.766907
Sharon-Lise Normand. 2008. “Some Old and Some New Statistical Tools for Outcomes Research”. Circulation, 118, 8, Pp. 872-84. doi:10.1161/CIRCULATIONAHA.108.766907
Laura Mauri, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Zheng Zhou, Frederic Resnic, and Sharon-Lise Normand. 2008. “Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts”. Circulation, 118, 18, Pp. 1817-27. doi:10.1161/CIRCULATIONAHA.108.781377
Laura Mauri, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Zheng Zhou, Frederic Resnic, and Sharon-Lise Normand. 2008. “Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts”. Circulation, 118, 18, Pp. 1817-27. doi:10.1161/CIRCULATIONAHA.108.781377
Laura Mauri, Treacy Silbaugh, Pallav Garg, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Sharon-Lise Normand. 2008. “Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction”. N Engl J Med, 359, 13, Pp. 1330-42. doi:10.1056/NEJMoa0801485
Laura Mauri, Treacy Silbaugh, Pallav Garg, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Sharon-Lise Normand. 2008. “Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction”. N Engl J Med, 359, 13, Pp. 1330-42. doi:10.1056/NEJMoa0801485
Pallav Garg, Sharon-Lise Normand, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Laura Mauri. 2008. “Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results from the Massachusetts Data Analysis Center Registry”. Circulation, 118, 22, Pp. 2277-85, 7p following 2285. doi:10.1161/CIRCULATIONAHA.108.820159
Pallav Garg, Sharon-Lise Normand, Treacy Silbaugh, Robert Wolf, Katya Zelevinsky, Ann Lovett, Manu Varma, Zheng Zhou, and Laura Mauri. 2008. “Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus: Results from the Massachusetts Data Analysis Center Registry”. Circulation, 118, 22, Pp. 2277-85, 7p following 2285. doi:10.1161/CIRCULATIONAHA.108.820159

2009

Justin Timbie, David Shahian, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2009. “Composite Measures for Hospital Quality Using Quality-Adjusted Life Years”. Stat Med, 28, 8, Pp. 1238-54. doi:10.1002/sim.3539
Justin Timbie, David Shahian, Joseph Newhouse, Meredith Rosenthal, and Sharon-Lise Normand. 2009. “Composite Measures for Hospital Quality Using Quality-Adjusted Life Years”. Stat Med, 28, 8, Pp. 1238-54. doi:10.1002/sim.3539
Luis Castellanos, Sharon-Lise Normand, and John Ayanian. 2009. “Racial and Ethnic Disparities in Access to Higher and Lower Quality Cardiac Surgeons for Coronary Artery Bypass Grafting”. Am J Cardiol, 103, 12, Pp. 1682-6. doi:10.1016/j.amjcard.2009.02.019
Luis Castellanos, Sharon-Lise Normand, and John Ayanian. 2009. “Racial and Ethnic Disparities in Access to Higher and Lower Quality Cardiac Surgeons for Coronary Artery Bypass Grafting”. Am J Cardiol, 103, 12, Pp. 1682-6. doi:10.1016/j.amjcard.2009.02.019

2011

David Charytan, Manu Varma, Treacy Silbaugh, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2011. “Long-Term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry”. Am J Kidney Dis, 57, 2, Pp. 202-11. doi:10.1053/j.ajkd.2010.09.017
David Charytan, Manu Varma, Treacy Silbaugh, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2011. “Long-Term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry”. Am J Kidney Dis, 57, 2, Pp. 202-11. doi:10.1053/j.ajkd.2010.09.017
Kurt Barringhaus, Katya Zelevinsky, Ann Lovett, Sharon-Lise Normand, and Kalon Ho. 2011. “Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts”. Circ Cardiovasc Qual Outcomes, 4, 1, Pp. 92-8. doi:10.1161/CIRCOUTCOMES.110.957597
Kurt Barringhaus, Katya Zelevinsky, Ann Lovett, Sharon-Lise Normand, and Kalon Ho. 2011. “Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts”. Circ Cardiovasc Qual Outcomes, 4, 1, Pp. 92-8. doi:10.1161/CIRCOUTCOMES.110.957597
Frederic Resnic, Sharon-Lise Normand, Thomas Piemonte, Samuel Shubrooks, Katya Zelevinsky, Ann Lovett, and Kalon Ho. 2011. “Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention through the Addition of a ‘compassionate Use’ Variable to the National Cardiovascular Data Registry CathPCI Dataset: A Study from the Massachusetts Angioplasty Registry”. J Am Coll Cardiol, 57, 8, Pp. 904-11. doi:10.1016/j.jacc.2010.09.057
Frederic Resnic, Sharon-Lise Normand, Thomas Piemonte, Samuel Shubrooks, Katya Zelevinsky, Ann Lovett, and Kalon Ho. 2011. “Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention through the Addition of a ‘compassionate Use’ Variable to the National Cardiovascular Data Registry CathPCI Dataset: A Study from the Massachusetts Angioplasty Registry”. J Am Coll Cardiol, 57, 8, Pp. 904-11. doi:10.1016/j.jacc.2010.09.057
Robert Yeh, Sharon-Lise Normand, Robert Wolf, Philip Jones, Kalon Ho, David Cohen, Donald Cutlip, Laura Mauri, Aaron Kugelmass, Amit Amin, and John Spertus. 2011. “Predicting the Restenosis Benefit of Drug-Eluting versus Bare Metal Stents in Percutaneous Coronary Intervention”. Circulation, 124, 14, Pp. 1557-64. doi:10.1161/CIRCULATIONAHA.111.045229
Robert Yeh, Sharon-Lise Normand, Robert Wolf, Philip Jones, Kalon Ho, David Cohen, Donald Cutlip, Laura Mauri, Aaron Kugelmass, Amit Amin, and John Spertus. 2011. “Predicting the Restenosis Benefit of Drug-Eluting versus Bare Metal Stents in Percutaneous Coronary Intervention”. Circulation, 124, 14, Pp. 1557-64. doi:10.1161/CIRCULATIONAHA.111.045229

2012

David Shahian, Lisa Iezzoni, Gregg Meyer, Leslie Kirle, and Sharon-Lise Normand. 2012. “Hospital-Wide Mortality As a Quality Metric: Conceptual and Methodological Challenges”. Am J Med Qual, 27, 2, Pp. 112-23. doi:10.1177/1062860611412358
David Shahian, Lisa Iezzoni, Gregg Meyer, Leslie Kirle, and Sharon-Lise Normand. 2012. “Hospital-Wide Mortality As a Quality Metric: Conceptual and Methodological Challenges”. Am J Med Qual, 27, 2, Pp. 112-23. doi:10.1177/1062860611412358
Robert Yeh, Sharon-Lise Normand, Yun Wang, Christopher Barr, and Francesca Dominici. 2012. “Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats?”. Circ Cardiovasc Qual Outcomes, 5, 2, Pp. 197-204. doi:10.1161/CIRCOUTCOMES.111.962456
Robert Yeh, Sharon-Lise Normand, Yun Wang, Christopher Barr, and Francesca Dominici. 2012. “Geographic Disparities in the Incidence and Outcomes of Hospitalized Myocardial Infarction: Does a Rising Tide Lift All Boats?”. Circ Cardiovasc Qual Outcomes, 5, 2, Pp. 197-204. doi:10.1161/CIRCOUTCOMES.111.962456
Sotiris Stamou, Michael Robich, Robert Wolf, Ann Lovett, Sharon-Lise Normand, and Frank Sellke. 2012. “Effects of Gender and Ethnicity on Outcomes After Aortic Valve Replacement”. J Thorac Cardiovasc Surg, 144, 2, Pp. 486-92. doi:10.1016/j.jtcvs.2011.11.023
Sotiris Stamou, Michael Robich, Robert Wolf, Ann Lovett, Sharon-Lise Normand, and Frank Sellke. 2012. “Effects of Gender and Ethnicity on Outcomes After Aortic Valve Replacement”. J Thorac Cardiovasc Surg, 144, 2, Pp. 486-92. doi:10.1016/j.jtcvs.2011.11.023
Amit Amin, John Spertus, David Cohen, Adnan Chhatriwalla, Kevin Kennedy, Katherine Vilain, Adam Salisbury, Lakshmi Venkitachalam, Sue Min Lai, Laura Mauri, Sharon-Lise Normand, John Rumsfeld, John Messenger, and Robert Yeh. 2012. “Use of Drug-Eluting Stents As a Function of Predicted Benefit: Clinical and Economic Implications of Current Practice”. Arch Intern Med, 172, 15, Pp. 1145-52. doi:10.1001/archinternmed.2012.3093
Amit Amin, John Spertus, David Cohen, Adnan Chhatriwalla, Kevin Kennedy, Katherine Vilain, Adam Salisbury, Lakshmi Venkitachalam, Sue Min Lai, Laura Mauri, Sharon-Lise Normand, John Rumsfeld, John Messenger, and Robert Yeh. 2012. “Use of Drug-Eluting Stents As a Function of Predicted Benefit: Clinical and Economic Implications of Current Practice”. Arch Intern Med, 172, 15, Pp. 1145-52. doi:10.1001/archinternmed.2012.3093
Venkatesan Vidi, Michael Matheny, Usha Govindarajulu, Sharon-Lise Normand, Susan Robbins, Vikram Agarwal, Sripal Bangalore, and Frederic Resnic. 2012. “Vascular Closure Device Failure in Contemporary Practice”. JACC Cardiovasc Interv, 5, 8, Pp. 837-44. doi:10.1016/j.jcin.2012.05.005
Venkatesan Vidi, Michael Matheny, Usha Govindarajulu, Sharon-Lise Normand, Susan Robbins, Vikram Agarwal, Sripal Bangalore, and Frederic Resnic. 2012. “Vascular Closure Device Failure in Contemporary Practice”. JACC Cardiovasc Interv, 5, 8, Pp. 837-44. doi:10.1016/j.jcin.2012.05.005
Robert Yeh, Kenneth Rosenfield, Katya Zelevinsky, Laura Mauri, Rahul Sakhuja, Daniel Shivapour, Ann Lovett, Bonnie Weiner, Alice Jacobs, and Sharon-Lise Normand. 2012. “Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention”. Circ Cardiovasc Interv, 5, 2, Pp. 227-36. doi:10.1161/CIRCINTERVENTIONS.111.967638
Robert Yeh, Kenneth Rosenfield, Katya Zelevinsky, Laura Mauri, Rahul Sakhuja, Daniel Shivapour, Ann Lovett, Bonnie Weiner, Alice Jacobs, and Sharon-Lise Normand. 2012. “Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention”. Circ Cardiovasc Interv, 5, 2, Pp. 227-36. doi:10.1161/CIRCINTERVENTIONS.111.967638

2013

John Bittl, Yulei He, Alice Jacobs, Clyde Yancy, and Sharon-Lise Normand. 2013. “Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease”. Circulation, 127, 22, Pp. 2177-85. doi:10.1161/CIRCULATIONAHA.112.000646
John Bittl, Yulei He, Alice Jacobs, Clyde Yancy, and Sharon-Lise Normand. 2013. “Bayesian Methods Affirm the Use of Percutaneous Coronary Intervention to Improve Survival in Patients With Unprotected Left Main Coronary Artery Disease”. Circulation, 127, 22, Pp. 2177-85. doi:10.1161/CIRCULATIONAHA.112.000646
Daniel Kramer, Kevin Kennedy, Peter Noseworthy, Alfred Buxton, Mark Josephson, Sharon-Lise Normand, John Spertus, Peter Zimetbaum, Matthew Reynolds, and Susan Mitchell. 2013. “Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results from the NCDR”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 488-97. doi:10.1161/CIRCOUTCOMES.111.000054
Daniel Kramer, Kevin Kennedy, Peter Noseworthy, Alfred Buxton, Mark Josephson, Sharon-Lise Normand, John Spertus, Peter Zimetbaum, Matthew Reynolds, and Susan Mitchell. 2013. “Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results from the NCDR”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 488-97. doi:10.1161/CIRCOUTCOMES.111.000054
Jason Wasfy, Kenneth Rosenfield, Katya Zelevinsky, Rahul Sakhuja, Ann Lovett, John Spertus, Neil Wimmer, Laura Mauri, Sharon-Lise Normand, and Robert Yeh. 2013. “A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 429-35. doi:10.1161/CIRCOUTCOMES.111.000093
Jason Wasfy, Kenneth Rosenfield, Katya Zelevinsky, Rahul Sakhuja, Ann Lovett, John Spertus, Neil Wimmer, Laura Mauri, Sharon-Lise Normand, and Robert Yeh. 2013. “A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention”. Circ Cardiovasc Qual Outcomes, 6, 4, Pp. 429-35. doi:10.1161/CIRCOUTCOMES.111.000093
Alice Jacobs, Sharon-Lise Normand, Joseph Massaro, Donald Cutlip, Joseph Carrozza, Anthony Marks, Nancy Murphy, Iyah Romm, Madeleine Biondolillo, and Laura Mauri. 2013. “Nonemergency PCI at Hospitals With or Without On-Site Cardiac Surgery”. N Engl J Med, 368, 16, Pp. 1498-508. doi:10.1056/NEJMoa1300610
Alice Jacobs, Sharon-Lise Normand, Joseph Massaro, Donald Cutlip, Joseph Carrozza, Anthony Marks, Nancy Murphy, Iyah Romm, Madeleine Biondolillo, and Laura Mauri. 2013. “Nonemergency PCI at Hospitals With or Without On-Site Cardiac Surgery”. N Engl J Med, 368, 16, Pp. 1498-508. doi:10.1056/NEJMoa1300610

2014

Jason Wasfy, Jordan Strom, Cashel O’Brien, Adrian Zai, Jennifer Luttrell, Kevin Kennedy, John Spertus, Katya Zelevinsky, Sharon-Lise Normand, Laura Mauri, and Robert Yeh. 2014. “Causes of Short-Term Readmission After Percutaneous Coronary Intervention”. Circ Cardiovasc Interv, 7, 1, Pp. 97-103. doi:10.1161/CIRCINTERVENTIONS.113.000988
Jason Wasfy, Jordan Strom, Cashel O’Brien, Adrian Zai, Jennifer Luttrell, Kevin Kennedy, John Spertus, Katya Zelevinsky, Sharon-Lise Normand, Laura Mauri, and Robert Yeh. 2014. “Causes of Short-Term Readmission After Percutaneous Coronary Intervention”. Circ Cardiovasc Interv, 7, 1, Pp. 97-103. doi:10.1161/CIRCINTERVENTIONS.113.000988
Robert Yeh, Samip Vasaiwala, Daniel Forman, Treacy Silbaugh, Katya Zelevinski, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2014. “Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly”. Circ Cardiovasc Qual Outcomes, 7, 1, Pp. 118-24. doi:10.1161/CIRCOUTCOMES.113.000476
Robert Yeh, Samip Vasaiwala, Daniel Forman, Treacy Silbaugh, Katya Zelevinski, Ann Lovett, Sharon-Lise Normand, and Laura Mauri. 2014. “Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly”. Circ Cardiovasc Qual Outcomes, 7, 1, Pp. 118-24. doi:10.1161/CIRCOUTCOMES.113.000476
Michelle Albert, John Ayanian, Treacy Silbaugh, Ann Lovett, Fred Resnic, Aryana Jacobs, and Sharon-Lise Normand. 2014. “Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care”. Circulation, 129, 24, Pp. 2528-38. doi:10.1161/CIRCULATIONAHA.113.005231
Michelle Albert, John Ayanian, Treacy Silbaugh, Ann Lovett, Fred Resnic, Aryana Jacobs, and Sharon-Lise Normand. 2014. “Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care”. Circulation, 129, 24, Pp. 2528-38. doi:10.1161/CIRCULATIONAHA.113.005231

2017

Abdallah Alameddine, Paul Visintainer, Sharon-Lise Normand, Robert Wolf, and Yvonne Alameddine. 2017. “Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report”. Am J Clin Oncol, 40, 2, Pp. 122-24. doi:10.1097/COC.0000000000000120
Abdallah Alameddine, Paul Visintainer, Sharon-Lise Normand, Robert Wolf, and Yvonne Alameddine. 2017. “Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report”. Am J Clin Oncol, 40, 2, Pp. 122-24. doi:10.1097/COC.0000000000000120

2015

Sripal Bangalore, Treacy Silbaugh, Sharon-Lise Normand, Ann Lovett, Frederick Welt, and Frederic Resnic. 2015. “Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery”. Catheter Cardiovasc Interv, 85, 4, Pp. 533-41. doi:10.1002/ccd.25617
Sripal Bangalore, Treacy Silbaugh, Sharon-Lise Normand, Ann Lovett, Frederick Welt, and Frederic Resnic. 2015. “Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery”. Catheter Cardiovasc Interv, 85, 4, Pp. 533-41. doi:10.1002/ccd.25617

2016

Jacob Spertus V, Sharon-Lise T Normand, Robert Wolf, Matt Cioffi, Ann Lovett, and Sherri Rose. 2016. “Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data.”. Circulation. Cardiovascular Quality and Outcomes, 9, 6, Pp. 659-69. doi:10.1161/CIRCOUTCOMES.116.002826
Jacob Spertus V, Sharon-Lise T Normand, Robert Wolf, Matt Cioffi, Ann Lovett, and Sherri Rose. 2016. “Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data.”. Circulation. Cardiovascular Quality and Outcomes, 9, 6, Pp. 659-69. doi:10.1161/CIRCOUTCOMES.116.002826

2003

David M Shahian and Sharon-Lise T Normand. 2003. “The Volume-Outcome Relationship: From Luft to Leapfrog.”. The Annals of Thoracic Surgery, 75, 3, Pp. 1048-58
David M Shahian and Sharon-Lise T Normand. 2003. “The Volume-Outcome Relationship: From Luft to Leapfrog.”. The Annals of Thoracic Surgery, 75, 3, Pp. 1048-58

2001

D M Shahian, S L Normand, D F Torchiana, S M Lewis, J O Pastore, R E Kuntz, and P I Dreyer. 2001. “Cardiac Surgery Report Cards: Comprehensive Review and Statistical Critique.”. The Annals of Thoracic Surgery, 72, 6, Pp. 2155-68
D M Shahian, S L Normand, D F Torchiana, S M Lewis, J O Pastore, R E Kuntz, and P I Dreyer. 2001. “Cardiac Surgery Report Cards: Comprehensive Review and Statistical Critique.”. The Annals of Thoracic Surgery, 72, 6, Pp. 2155-68